Business Context and Reporting Period
This Form 8-K is a current report filed by Quaker Chemical Corporation on December 5, 2024. The filing addresses the formalization of the separation agreement with Andrew E. Tometich, who departed as Chief Executive Officer, President, and Board member effective November 18, 2024.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation and separation terms rather than operational financial results.
Material Changes
The primary material change is the execution of a Separation Agreement and General Release on December 5, 2024, regarding Mr. Tometich's involuntary termination. The agreement modifies previously reported severance terms to include accelerated, prorated vesting of outstanding equity awards (Stock Options, Restricted Stock Units, Performance Stock Units, and Restricted Stock) under the 2016 Long-Term Incentive Plan.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The document notes that Mr. Tometich's departure was not related to any disagreement with the Company. Performance-based awards will be measured at the end of their respective periods and paid if earned.
Investor Verification Checklist
- Verify the specific dollar value of severance payments referenced in the November 20, 2024, Form 8-K and the March 28, 2024, proxy statement.
- Review the full text of the Separation Agreement (Exhibit 10.1) for detailed conditions on the accelerated vesting of equity awards.
- Confirm the timeline for the payout of Performance Stock Units (PSUs) relative to the end of their performance periods.
- Monitor subsequent filings for the appointment of a new Chief Executive Officer and President.